<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>CYPRI Score Calculator</title>
<style>
body {
    font-family: Arial, sans-serif;
    margin: 40px;
    max-width: 900px;
}
h1 { color: #2c3e50; }
.criterion-box {
    border: 2px solid #2c3e50;
    border-radius: 8px;
    padding: 20px;
    margin-bottom: 35px;
    color: black;
}
.criterion-box:nth-of-type(1) { background-color: #fde725; }
.criterion-box:nth-of-type(2) { background-color: #a0da39; }
.criterion-box:nth-of-type(3) { background-color: #4ac16d; }
.criterion-box:nth-of-type(4) { background-color: #1fa187; }
.criterion-box:nth-of-type(5) { background-color: #3b528b; }
.details {
    font-size: 14px;
    margin-top: 12px;
    background: rgba(255, 255, 255, 0.4);
    padding: 12px;
    border-left: 3px solid #2c3e50;
    white-space: pre-line;
}
fieldset {
    border: 2px solid #2c3e50;
    border-radius: 8px;
    padding: 30px;
    margin-bottom: 35px;
    margin-top: 0;
    background-color: #21918c;
    color: black;
}
.legend-title {
    font-weight: bold;
    color: #2c3e50;
    font-size: 18px;
    margin-bottom: 20px;
    padding: 10px;
}
button {
    margin-top: 30px;
    padding: 12px 20px;
    font-size: 18px;
    cursor: pointer;
}
#result {
    margin-top: 25px;
    font-size: 22px;
    font-weight: bold;
}
#interpretation {
    margin-top: 20px;
    font-size: 20px;
    font-weight: bold;
    color: red;
}
</style>
</head>
<body>

<h1>CYPRI Score Calculator</h1>

<form id="cypri-form">

<div class="criterion-box">
<label><input type="checkbox" name="psychiatric_med"> The use of psychiatric medication (1 point)</label>
<div class="details">
Psychiatric drugs are classified as CYP2D6/CYP2C19 substrates according to the Hiemke 2018 Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry, Flockhart Table, Pharmacogenomics Knowledge Base, CPIC, and DPWG guidelines for PGx-based drug metabolism impact [1,2,3,4,5].<br><br>Examples:<br>atomoxetine, modafinil, amitriptyline, nortriptyline, paroxetine, citalopram, escitalopram, fluoxetine, aripiprazole, risperidone, diazepam, venlafaxine.
</div>
</div>

<div class="criterion-box">
<label><input type="checkbox" name="somatic_med"> The use of somatic medication (1 point)</label>
<div class="details">
Non-psychiatric drugs that are also substrates for CYP2D6 and CYP2C19 according to the Flockhart Table, Pharmacogenomics Knowledge Base, CPIC, and DPWG guidelines [2,3,4,5].<br><br>Examples:<br>clopidogrel, codeine, tramadol, omeprazole, pantoprazole, ondansetron, metoclopramide, voriconazole, metoprolol, propafenone.
</div>
</div>

<div class="criterion-box">
<label><input type="checkbox" name="treatment_resistance"> Treatment-resistant condition (1 point)</label>
<div class="details">
Defined as the failure of two or more adequate medication trials despite verified adherence and appropriate dosing [6].
</div>
</div>

<fieldset>
<div class="legend-title">Drug plasma levels (choose one)</div>

<label><input type="radio" name="tdm" value="3"> Drug plasma levels do not correlate with the administered dose (3 points)</label>
<div class="details">
Based on therapeutic drug monitoring (TDM) results [1], defined as:<br>
- High dose with subtherapeutic drug levels (suggesting ultra-/rapid metabolism), OR<br>
- Low dose with supratherapeutic/toxic drug levels (suggesting intermediate/poor metabolism).
</div>

<label><input type="radio" name="tdm" value="1"> Plasma drug concentration falls outside the established minimum-maximum range (1 point)</label>
<div class="details">
- Plasma drug concentration falls outside the established minimum-maximum range (C/Dlow and C/Dhigh) for the specific drug according to Hiemke 2018 [1], OR<br>
- Altered parent drug/metabolite ratio, indicating non-normal CYP2D6/CYP2C19 metabolism (e.g., venlafaxine, risperidone, aripiprazole).
</div>

<label><input type="radio" name="tdm" value="0" checked> None</label>
</fieldset>

<div class="criterion-box">
<label><input type="checkbox" name="adr"> Clinically significant adverse drug reactions (3 points)</label>
<div class="details">
Based solely on clinical observation and pharmacological history, the following criteria are the results of an ADR:<br>
- Requiring dose adjustment,<br>
- Increased monitoring,<br>
- Drug discontinuation due to intolerance or toxicity,<br>
- Hospitalization due to ADR,<br>
- Patient is unable to tolerate the drug despite standard dosing (reliable information from pharmacologic history, e.g. medical opinion).<br><br>
ADRs not linked to CYP2C19/CYP2D6 metabolism variability (concentration-dependent ADRs), such as allergic or immunologically mediated reactions and weight gain, are excluded [1,7,8].
</div>
</div>

<button type="button" onclick="calculateScore()">Calculate Score</button>
</form>

<h2 id="result"></h2>
<p id="interpretation"></p>

<h3>References:</h3>
<ol>
<li>Hiemke, C. et al. (2018). Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017. Pharmacopsychiatry.</li>
<li>Indiana University Drug Interactions Table.</li>
<li>PharmGKB Database.</li>
<li>CPIC Guidelines.</li>
<li>DPWG Guidelines.</li>
<li>Howes O. et al., Treatment resistance in psychiatry, Molecular Psychiatry, 2022.</li>
<li>Lingjaerde, O. et al., UKU-SERS-Pat (2001).</li>
<li>Dreher, J. et al., ADR scale (1999).</li>
</ol>

<script>
function calculateScore() {
    let score = 0;
    score += document.querySelector('input[name="psychiatric_med"]').checked ? 1 : 0;
    score += document.querySelector('input[name="somatic_med"]').checked ? 1 : 0;
    score += document.querySelector('input[name="treatment_resistance"]').checked ? 1 : 0;
    score += parseInt(document.querySelector('input[name="tdm"]:checked').value);
    score += document.querySelector('input[name="adr"]').checked ? 3 : 0;

    document.getElementById("result").innerText = "Total CYPRI Score: " + score;

    let interpretation = "";
    if (score >= 4) {
        interpretation = "Patient is highly likely to benefit from pharmacogenetic testing. Testing is recommended.";
    } else {
        interpretation = "Patient is unlikely to benefit from pharmacogenetic testing based on clinical criteria. Testing is not routinely recommended.";
    }
    document.getElementById("interpretation").innerText = interpretation;
}
</script>

</body>
</html>
